Brian T. Powl insider trades

Open-market stock purchases and sales by Brian T. Powl, Chief Commercial Officer at Kura Oncology, Inc, from SEC Form 4 filings since Jun 27, 2022.

Recent trades

DateStockTradeValue
May 21, 2026KURA Kura Oncology, IncSold$110K
May 19, 2026KURA Kura Oncology, IncSold$3.1K
Jan 27, 2026KURA Kura Oncology, IncSold$41K
Jan 27, 2026KURA Kura Oncology, IncSold$13.3K
Jan 2, 2026KURA Kura Oncology, IncBought (not open market)—
Jan 2, 2026KURA Kura Oncology, IncBought (not open market)—
Nov 14, 2025KURA Kura Oncology, IncSold$99.3K
Nov 13, 2025KURA Kura Oncology, IncBought (not open market)—

Companies traded

  • KURA Kura Oncology, Inc: 7 sales, last May 21, 2026
  • FATE Fate Therapeutics Inc: 1 sale, last Jul 5, 2023

Get free alerts when Brian T. Powl files a new trade →